Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18260994rdf:typepubmed:Citationlld:pubmed
pubmed-article:18260994lifeskim:mentionsumls-concept:C0020538lld:lifeskim
pubmed-article:18260994lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:18260994lifeskim:mentionsumls-concept:C0020428lld:lifeskim
pubmed-article:18260994lifeskim:mentionsumls-concept:C0314657lld:lifeskim
pubmed-article:18260994lifeskim:mentionsumls-concept:C1413857lld:lifeskim
pubmed-article:18260994lifeskim:mentionsumls-concept:C1366631lld:lifeskim
pubmed-article:18260994lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:18260994lifeskim:mentionsumls-concept:C1419338lld:lifeskim
pubmed-article:18260994lifeskim:mentionsumls-concept:C1427479lld:lifeskim
pubmed-article:18260994lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:18260994pubmed:issue1lld:pubmed
pubmed-article:18260994pubmed:dateCreated2008-2-11lld:pubmed
pubmed-article:18260994pubmed:abstractTextWe carried out comparison of distribution of alleles and genotypes of polymorphic loci of renin-angiotensin-aldosterone system genes: CYP11B2 (C-344T), AGT (Thr174Met) and REN (C-5434T, C-5312T, and A BglI G) and their combinations in two groups of patients with low renin forms of arterial hypertension (AH). Group 1 included 59 patients with low renin hyperaldosteronism (HA) at the background of glomerular zone adenoma and hyperplasia of adrenal cortex. Group 2 included 28 patients with low renin hypertensive disease characterized by normal level of aldosterone. Complex analysis of carriership of allele and genotype combinations evidence for the difference in genetic nature of two forms of low renin AH. Participation of CYP11B2 and REN and possibly AGT genes in development of low renin AH was convincingly shown.lld:pubmed
pubmed-article:18260994pubmed:languageruslld:pubmed
pubmed-article:18260994pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18260994pubmed:citationSubsetIMlld:pubmed
pubmed-article:18260994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18260994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18260994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18260994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18260994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18260994pubmed:statusMEDLINElld:pubmed
pubmed-article:18260994pubmed:issn0022-9040lld:pubmed
pubmed-article:18260994pubmed:authorpubmed-author:FavorovaO OOOlld:pubmed
pubmed-article:18260994pubmed:authorpubmed-author:ChikhladzeN...lld:pubmed
pubmed-article:18260994pubmed:authorpubmed-author:ChazovaI EIElld:pubmed
pubmed-article:18260994pubmed:authorpubmed-author:SudomoinaM...lld:pubmed
pubmed-article:18260994pubmed:authorpubmed-author:FavorovA VAVlld:pubmed
pubmed-article:18260994pubmed:authorpubmed-author:ThantMyoMlld:pubmed
pubmed-article:18260994pubmed:authorpubmed-author:SamedovaKh...lld:pubmed
pubmed-article:18260994pubmed:authorpubmed-author:HtutZaw MinZMlld:pubmed
pubmed-article:18260994pubmed:authorpubmed-author:LitonovaG NGNlld:pubmed
pubmed-article:18260994pubmed:issnTypePrintlld:pubmed
pubmed-article:18260994pubmed:volume48lld:pubmed
pubmed-article:18260994pubmed:ownerNLMlld:pubmed
pubmed-article:18260994pubmed:authorsCompleteYlld:pubmed
pubmed-article:18260994pubmed:pagination37-42lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:meshHeadingpubmed-meshheading:18260994...lld:pubmed
pubmed-article:18260994pubmed:year2008lld:pubmed
pubmed-article:18260994pubmed:articleTitle[Contribution of CYP11B2, REN and AGT genes in genetic predisposition to arterial hypertension associated with hyperaldosteronism].lld:pubmed
pubmed-article:18260994pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18260994pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18260994pubmed:publicationTypeEnglish Abstractlld:pubmed
entrez-gene:183entrezgene:pubmedpubmed-article:18260994lld:entrezgene
entrez-gene:1585entrezgene:pubmedpubmed-article:18260994lld:entrezgene
entrez-gene:5972entrezgene:pubmedpubmed-article:18260994lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18260994lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18260994lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18260994lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18260994lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18260994lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18260994lld:entrezgene